Emerging data with immunotherapy in ESCC and potential impact for clinical practice

February 7, 2022

touchTALKS for touchONCOLOLOGY

Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC) 

The expert

  • Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK


Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from ESMO Congress 2022 (to follow)
Part 4: Insights from 2022 – a round up (to follow)

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME. 

For further information visit our website:

Podbean App

Play this podcast on Podbean App